Latest Technology Development News

Carnegie Clean Energy reported a $2.33 million net loss for FY2025 but made significant strides in commercialising its wave energy technologies, supported by new loans and a US subsidiary launch.

Viridis Mining and Minerals has significantly expanded its Colossus Rare Earth Elements project in Brazil, securing an additional 2,503.6 hectares adjacent to its existing licenses. This move, backed by robust government support and strategic partnerships, enhances the project's scale and de-risks its pathway to production.

Xamble Group Limited (ASX, XGL) has announced a pro-rata renounceable entitlement offer to raise up to A$1.36 million, including free attaching options exercisable until 2028. The offer is partially underwritten by Eli Capital Pty Limited and aims to accelerate platform growth and technology development.

ClearVue Technologies has responded to ASX concerns after its CEO described previous project pipeline announcements as ‘fairy tales,’ affirming prior disclosures were accurate despite some project setbacks.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

AML3D Limited reported a modest increase in revenue for FY2025 but saw its losses widen significantly, raising questions about its path to profitability.

Tetratherix has landed a $3.3 million Australian Government grant to co-fund a $7.4 million project expanding its synthetic polymer production and supporting its US market entry in 2026.

ikeGPS has dramatically exceeded its $2 million target in a recent share purchase plan, raising over $8 million to fuel its growth ambitions. The strong shareholder backing underscores confidence in the company’s strategic direction.

Pure Resources Limited reports exceptional metallurgical results from its Garnet Hills Project, achieving garnet grades up to 98% and advancing scalable, sustainable processing methods aligned with industrial demand. The company is also forging strategic US collaborations to unlock downstream opportunities.

Imagion Biosystems has completed the first tranche of its $3.5 million capital raising, issuing 45 million new shares to strengthen its financial position ahead of a key shareholder vote.

Adisyn Ltd has initiated a pivotal phase in its graphene interconnect technology development, commissioning a state-of-the-art Atomic Layer Deposition system and collaborating globally to tackle semiconductor bottlenecks.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.